Volume 43, Issue 4, 21 January 2022

Issue @ A Glance

Cardio-oncology: a focus on cardiovascular toxicities of cancer therapies and on atrial fibrillation in cancer

Filippo Crea

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 245–248, https://doi.org/10.1093/eurheartj/ehab905

• Extract
• View article

CardioPulse

How to live to 100 before developing clinical coronary artery disease: a suggestion

Eugene Braunwald

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 249–250, https://doi.org/10.1093/eurheartj/ehab532

• Extract
• View article

Screening professional athletes for cardiovascular diseases at risk of cardiac arrest

Domenico Corrado and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 251–254, https://doi.org/10.1093/eurheartj/ehab440

• Extract
• View article

Leading the cardiology arena in Egypt

Mark Nicholls

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 255–256, https://doi.org/10.1093/eurheartj/ehab397

• Extract
• View article

Use of chronic kidney disease blind spot to prevent cardiorenal outcomes

Luis M. Ruilope and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 257–260, https://doi.org/10.1093/eurheartj/ehab456

• Extract
• View article

CardioPulse

Weekly Journal Scan

Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study

Maria Lucia Narducci and Massimo Volpe

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 261–262, https://doi.org/10.1093/eurheartj/ehab796

• Extract
• View article

Special Article

Diabetes and Metabolic Disorders

The year in cardiovascular medicine 2021: diabetes and metabolic disorders

Francesco Cosentino and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 263–270, https://doi.org/10.1093/eurheartj/ehab876

• Abstracts
• View article

Digital Health and Innovation

The year in cardiovascular medicine 2021: digital health and innovation

Panos E. Vardas and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 271–279, https://doi.org/10.1093/eurheartj/ehab874

• Abstracts
• View article

Cardio-Oncology

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Joerg Herrmann and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 280–299, https://doi.org/10.1093/eurheartj/ehab674

• Abstracts
• View article
• Supplementary data

Fast Track Clinical Research

Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis

Avirup Guha and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 300–312, https://doi.org/10.1093/eurheartj/ehab745

• Abstracts
• View article
• Supplementary data

Editorial

Atrial fibrillation and breast cancer: casual or causal relationship?

Jose L Merino

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 313–315, https://doi.org/10.1093/eurheartj/ehab807

• Abstract
• View article

Clinical Research

Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy

Lars Michel and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 316–329, https://doi.org/10.1093/eurheartj/ehab430

• Abstracts
• View article
• Supplementary data

Editorial

Novel actors on the stage of cardiac dysfunction induced by anti-PD1 oncological treatments

Gilda Varricchi and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 330–332, https://doi.org/10.1093/eurheartj/ehab584

• Extract
• View article

Clinical Research

Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis

Oliver C Cohen and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 333–341, https://doi.org/10.1093/eurheartj/ehab507

• Abstracts
• View article
• Supplementary data

Editorial

Longitudinal strain in the management of cardiac AL amyloidosis: do we need it?

Claudio Rapezzi and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 342–344, https://doi.org/10.1093/eurheartj/ehab609

• Extract
• View article

Discussion Forum

Iron therapy on quality of life in acute heart failure: alternative approaches

Konrad Teodor Sawicki and Hossein Ardehali

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 345–346, https://doi.org/10.1093/eurheartj/ehab823

• Extract
• View article

Dilemmas on diagnosis and treatment of iron deficiency in patients after an episode of acute heart failure

Ewa A Jankowska and Piotr Ponikowski

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 347–348, https://doi.org/10.1093/eurheartj/ehab839

• Extract
• View article

Cardiovascular Flashlight

How to escape a catastrophic myocardial rupture by a whisker

Madeleine Barker and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Page 349, https://doi.org/10.1093/eurheartj/ehab641

• Extract
• View article

Primary malignant fibrous histiocytoma of the mitral valve as a rare incidental finding

Amr Idris and others

European Heart Journal, Volume 43, Issue 4, 21 January 2022, Page 350, https://doi.org/10.1093/eurheartj/ehaa860

• Extract
• View article
• Supplementary data